Skip to main content
. 2020 Mar 31;100(6):5714. doi: 10.2340/00015555-3454

Fig. 1.

Fig. 1

Clinical findings. (a) Multiple erosive red macules/papules with yellowish crusts on the lower extremities at the first visit. (b) Clinical appearance when prednisolone was discontinued. Only post-inflammatory pigmentation remained at the affected sites. (c) Schematic presentation of the clinical course. Nivo: nivolumab; RT: radiation therapy; PSL: prednisolone.